Personalis Receives $33M for Its Genome Diagnostic Tech
January 14, 2015
Personalis, a genomics-based clinical diagnostic lab, has completed a $33 million Series C equity round led by Lightspeed Venture Partners. The investment brings Personalis's funding total to $75 million, including a $22 million Series B financing that was raised at a valuation of $85 million in October 2013. Its technology consists of advanced genome-scale sequencing and interpretation services for inherited genetic disease and cancer.